Current Edition

Connect in Pharma launches partnerships for global health innovation

Sciad Newswire / Connect in Pharma announce today that for every visitor to the 2023 Geneva-based event, five Swiss francs will be donated to Global Health Security (GHS) Fund, a non-profit organisation driving local innovation and global programming to address threats to health security.

Connect in Pharma, taking place on 14 & 15 June 2023 in Geneva, brings together industry players across the pharmaceutical pipeline and biotechnology community and will also host an exhibition booth for the Global Health Security Fund.

The partnership aims to increase funding and awareness of global health security challenges and highlight the role of the pharmaceutical industry in increasing access to medicines and improving health worldwide.

Renan Joel, Divisional Director at Connect in Pharma, says: “We’re honoured to be partnering with Global Health Security Fund, further highlighting the important and complex links between the pharmaceutical industry and global health security.”

The Global Health Security Fund is comprised of innovators who create, develop, and scale sustainable solutions to global health security challenges, particularly in less developed nations and emerging innovation ecosystems. The organisation tackles issues such as health equity and access, public health solutions, infectious diseases, and many more.

“We welcome the opportunity to lead conversations on global health security challenges at this year’s Connect in Pharma conference,” President of the Global Health Security Fund Dr. Lisa McDonald shares, “GHS Fund is committed to supporting the growth of Geneva as a hub for pharmaceutical innovation. We look forward to meeting with industry experts from across Europe to ensure the future of pharma has a global perspective.”

Renan Joel, adds: “The COVID-19 pandemic highlighted inequalities in access to life-saving healthcare across the globe, and the difficulties of getting medicines to communities who need them. We must build robust and resilient global health systems that account for people in disadvantaged countries and engage in the necessary conversations and partnerships to do so.”

Connect in Pharma is continuing to strengthen links between pharma and global health, partnering with the Health Innovation Exchange (HIEx) to showcase at the 76 World Health Assembly side event in InterCon Geneva later in May. Dr Biju Jacob, Chief Technology Officer at HIEx, says: “HIEx portfolio Innovators will benefit hugely from Connect in Pharma as a single access point to explore synergies between both industries. As a neutral multilateral agency, established by global health entities at UNAIDS in 2018, HIEx catalyse digital transformation and technology adoption for emerging markets.”

During the Connect in Pharma event, Chief Global Health Officer for ApiJect Systems Dr. Edward Kelley and Secretary General at BioAlps Association Magali Bischof are set to deliver keynote talks addressing related global health issues, sharing their experience of working on the global deployment of COVID-19 vaccinations and of involvement in international summits in Davos, Africa, Asia, Latin America, Europe, and the Middle East.

About Connect in Pharma

Connect in Pharma is a fresh and exciting new event for the European pharmaceutical and biotechnology community, taking place in the heart of the market in Geneva.

The event has been launched in answer to feedback from the community to fill a gap in the market to have an event at the centre of the pharma and biotech world, namely Switzerland. It is designed to address the most critical issues and challenges of the industry in a pivotal time for the packaging market, as well as provide a forum for inspiration, learning, collaboration, networking and sourcing.

Find out more about Connect in Pharma, the agenda and exhibitors at https://www.connectinpharma.com/

About Global Health Security Fund (GHS Fund)

Based in Geneva, the Global Health Security Fund (GHS Fund) is a nonprofit organisation combining venture capital and entrepreneurship principles with traditional philanthropy to identify and scale the most promising locally driven global health innovations. We identify global health security innovations and validate innovations based on the Sustainable Development Goals (SDGs) impact and investment potential, connecting market-ready innovations with investors. To learn more, visit GHSFund.org. Join the conversation, visit us @GHSFund.

About Easyfairs

Easyfairs organises and hosts events, bringing communities together to visit the future.

Easyfairs currently organises 200 face-to-face events in 14 countries (Algeria, Belgium, Denmark, Finland, France, Germany, Italy, the Netherlands, Norway, Portugal, Spain, Sweden, Switzerland and the United Kingdom) and manages eight event venues in Belgium, the Netherlands and Sweden (Antwerp, Ghent, Mechelen, Brussels North, Namur, Gorinchem, Hardenberg, Malmö and Stockholm).

Easyfairs is passionate about “easifying” the life of customers and increasing the return on investment and return on time for professional communities through their all-in formulas, advanced technology and customer-centric approach. Their digital features and initiatives provide these communities with excellent opportunities to network effectively and do business throughout the year. They listen carefully to create compelling online formats that meet customers’ constantly evolving needs.

The Easyfairs Group employs 600 highly committed talents, deploys the best marketing and technology tools, and develops brands with a strong appeal to our stakeholder communities.

In 2018 Easyfairs was named Belgium’s “Entrepreneur of the Year®” and earned recognition as a Deloitte “Best Managed Company” and a “Great Place to Work”.  For the third year running, Deloitte conferred “Best Managed Company” status on Easyfairs in 2021. The company is ranked 17th on the list of the world’s leading exhibition companies. Visit the future with Easyfairs and find out more at www.easyfairs.com.